Literature DB >> 32495577

[Mechanism of Xuanfei Baidu Tang in treatment of COVID-19 based on network pharmacology].

Yi Wang1, Xiang Li2, Jun-Hua Zhang3, Rui Xue1, Jing-Yang Qian1, Xiao-Hui Zhang1, Han Zhang3, Qing-Quan Liu4, Xiao-Hui Fan1, Yi-Yu Cheng5, Bo-Li Zhang3.   

Abstract

The study aimed to investigate the multi-constituent, multi-target mechanism of Xuanfei Baidu Tang(XFBD) in the treatment of coronavirus disease 2019(COVID-19), through exploring the main ingredients and effective targets of XFBD, as well as analyzing the correlation between XFBD targets and COVID-19. The compounds of each herb in XFBD were collected from TCM-PTD, ETCM, TCMSP and SymMap database. Next, the information of meridian tropisms was collected from Chinese Pharmacopoeia(2015 edition), and the target information of the major constituents of XFBD were obtained from TCM-PTD, ETCM, TCMSP and TargetNet database. Subsequently, the target network model and the major modules were generated by Cytoscape, and the functional enrichment analysis of XFBD targets were completed by DAVID and STRING. As a result, ten of the 13 herbs in XFBD belonged to the lung meridian, and 326 of the 1 224 putative XFBD targets were associated with the disease target of COVID-19, among which 109 targets were enriched in the disease pathways of viral infection and lung injury. The main biological pathways regulated by the key XFBD targets included viral infection, energy metabolism, immunity and inflammation, parasites and bacterial infections. In conclusion, the therapeutic mechanism of XFBD in COVID-19 showed a multi-herb, multi-constituent, multi-target pattern, with lung as the chief targeted organ. By regulating a series of biological pathways closely related to the occurrence and development of diseases, XFBD plays a role in balancing immunity, eliminating inflammation, regulating hepatic and biliary metabolism and recovering energy metabolism balance.

Entities:  

Keywords:  Xuanfei Baidu Tang(XFBD); coronavirus disease 2019(COVID-19); energy metabolism; hepatic and biliary metabolism; immunity and inflammation; network pharmacology

Year:  2020        PMID: 32495577     DOI: 10.19540/j.cnki.cjcmm.20200325.401

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  11 in total

Review 1.  Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.

Authors:  Chang Li; Lin Wang; Linzhu Ren
Journal:  Virus Res       Date:  2020-06-24       Impact factor: 3.303

Review 2.  Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19).

Authors:  Yu-Feng Huang; Chen Bai; Fan He; Ying Xie; Hua Zhou
Journal:  Pharmacol Res       Date:  2020-05-21       Impact factor: 7.658

Review 3.  Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.

Authors:  Kai Huang; Pan Zhang; Zhenghao Zhang; Ji Youn Youn; Chen Wang; Hongchun Zhang; Hua Cai
Journal:  Pharmacol Ther       Date:  2021-03-31       Impact factor: 13.400

4.  Chinese Medicine in Fighting against Covid-19: Role and Inspiration.

Authors:  Jin-Gen Li; Hao Xu
Journal:  Chin J Integr Med       Date:  2021-01-08       Impact factor: 1.978

5.  Multimodal Identification by Transcriptomics and Multiscale Bioassays of Active Components in Xuanfeibaidu Formula to Suppress Macrophage-Mediated Immune Response.

Authors:  Lu Zhao; Hao Liu; Yingchao Wang; Shufang Wang; Dejin Xun; Yi Wang; Yiyu Cheng; Boli Zhang
Journal:  Engineering (Beijing)       Date:  2021-11-15       Impact factor: 7.553

6.  Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction.

Authors:  Huimin Yan; Jia Lu; Jiabao Wang; Lu Chen; Yu Wang; Lin Li; Lin Miao; Han Zhang
Journal:  Front Pharmacol       Date:  2021-10-19       Impact factor: 5.810

Review 7.  Combating COVID-19 with integrated traditional Chinese and Western medicine in China.

Authors:  Liqiang Ni; Lili Chen; Xia Huang; Chouping Han; Jianrong Xu; Hong Zhang; Xin Luan; Yongfang Zhao; Jianguang Xu; Weian Yuan; Hongzhuan Chen
Journal:  Acta Pharm Sin B       Date:  2020-06-27       Impact factor: 11.413

8.  The role played by traditional Chinese medicine in preventing and treating COVID-19 in China.

Authors:  Qingwei Li; Han Wang; Xiuyang Li; Yujiao Zheng; Yu Wei; Pei Zhang; Qiyou Ding; Jiaran Lin; Shuang Tang; Yikun Zhao; Linhua Zhao; Xiaolin Tong
Journal:  Front Med       Date:  2020-07-10       Impact factor: 4.592

Review 9.  Current status of traditional Chinese medicine for the treatment of COVID-19 in China.

Authors:  Liang Chu; Fang Huang; Mengdan Zhang; Biao Huang; Yigang Wang
Journal:  Chin Med       Date:  2021-07-27       Impact factor: 5.455

Review 10.  Natural products and phytochemicals as potential anti-SARS-CoV-2 drugs.

Authors:  Myriam Merarchi; Namrata Dudha; Bhudev C Das; Manoj Garg
Journal:  Phytother Res       Date:  2021-06-16       Impact factor: 6.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.